Kinetic Binding Assay

Kinetic Binding Assay refers to experimental methods measuring the rates of association and dissociation between interacting molecules, such as drug compounds binding to protein targets or antibodies binding antigens. Unlike endpoint affinity assays that report equilibrium binding strength, kinetic assays provide dynamic information including on-rates, off-rates, and residence time, which can influence biological effects and dosing requirements.

The pharmaceutical industry uses kinetic binding assays to support lead optimisation and candidate selection, particularly for targets where binding duration correlates with efficacy. Technologies such as surface plasmon resonance and bio-layer interferometry provide real-time kinetic measurements. Kinetic data inform structure-activity relationships and guide medicinal chemistry efforts improving both potency and durability of action. In biologics development, kinetic binding profiles support antibody selection, epitope differentiation, and biosimilarity assessments. As drug discovery increasingly integrates biophysics and binding kinetics becomes recognised as a key driver of in vivo efficacy, kinetic binding assays remain valuable tools for mechanistic understanding and candidate optimisation.